Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucy Lee

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Brain : a Journal of Neurology|March 23, 2010
Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's diseaseMarjan Jahanshahi, Catherine R G Jones, Jan Zijlmans, et al.
Biopharmaceutics & Drug Disposition|February 12, 2004
In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteersYanfeng Wang, Lucy Lee, Russell Somma, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 22, 2006
Acute changes in frontoparietal activity after repetitive transcranial magnetic stimulation over the dorsolateral prefrontal cortex in a cued reaction time taskElisabeth Rounis, Klaas E Stephan, Lucy Lee, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 29, 2018
Monolithic Polymer Nanoridges with Programmable Wetting TransitionsWon-Kyu Lee, Woo-Bin Jung, Dongjoon Rhee, et al.
Pharmacology Research & Perspectives|March 20, 2023
A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti-SARS-CoV-2 (COVID-19) DHODH (dihydroorotate dehydrogenase) inhibitorTerri L Morton, Oscar L Laskin, Diksha Kaushik, et al.
Journal of Virology|November 12, 2003
Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cellsAlon M Levy, Yoshihiro Izumiya, Peter Brunovskis, et al.
Journal of Clinical Pharmacology|April 14, 2010
The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of RO5068760, an MEK inhibitor, in healthy volunteers: assessment of target suppressionLucy Lee, Huifeng Niu, Petra Goelzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Phase I study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of PTK787/ZK 222584 administered twice daily in patients with advanced cancerAnne L Thomas, Bruno Morgan, Mark A Horsfield, et al.
The European Journal of Neuroscience|July 28, 2005
How does transcranial DC stimulation of the primary motor cortex alter regional neuronal activity in the human brain?Nicolas Lang, Hartwig R Siebner, Nick S Ward, et al.
Brain : a Journal of Neurology|January 20, 2006
Motor system activation after subcortical stroke depends on corticospinal system integrityNick S Ward, Jennifer M Newton, Orlando B C Swayne, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Brain : a Journal of Neurology|March 23, 2010
Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's diseaseMarjan Jahanshahi, Catherine R G Jones, Jan Zijlmans, et al.
Biopharmaceutics & Drug Disposition|February 12, 2004
In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteersYanfeng Wang, Lucy Lee, Russell Somma, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 22, 2006
Acute changes in frontoparietal activity after repetitive transcranial magnetic stimulation over the dorsolateral prefrontal cortex in a cued reaction time taskElisabeth Rounis, Klaas E Stephan, Lucy Lee, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 29, 2018
Monolithic Polymer Nanoridges with Programmable Wetting TransitionsWon-Kyu Lee, Woo-Bin Jung, Dongjoon Rhee, et al.
Pharmacology Research & Perspectives|March 20, 2023
A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti-SARS-CoV-2 (COVID-19) DHODH (dihydroorotate dehydrogenase) inhibitorTerri L Morton, Oscar L Laskin, Diksha Kaushik, et al.
Journal of Virology|November 12, 2003
Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cellsAlon M Levy, Yoshihiro Izumiya, Peter Brunovskis, et al.
Journal of Clinical Pharmacology|April 14, 2010
The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of RO5068760, an MEK inhibitor, in healthy volunteers: assessment of target suppressionLucy Lee, Huifeng Niu, Petra Goelzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Phase I study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of PTK787/ZK 222584 administered twice daily in patients with advanced cancerAnne L Thomas, Bruno Morgan, Mark A Horsfield, et al.
The European Journal of Neuroscience|July 28, 2005
How does transcranial DC stimulation of the primary motor cortex alter regional neuronal activity in the human brain?Nicolas Lang, Hartwig R Siebner, Nick S Ward, et al.
Brain : a Journal of Neurology|January 20, 2006
Motor system activation after subcortical stroke depends on corticospinal system integrityNick S Ward, Jennifer M Newton, Orlando B C Swayne, et al.
Pageof 10